✦ LIBER ✦

HBA1C LEVELS ARE ASSOCIATED WITH LONG TERM MORTALITY RATES IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY

✍ Scribed by Havakuk, Ofer; Banai, Shmuel; Halkin, Amir; Berliner, Shlomo; Herz, Itzhak; Revivo, Miri; Konigstein, Maayan; Assa, Eyal Ben; Keren, Gad; Finkelstein, Ariel; Arbel, Yaron

Book ID: 122295129
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 364 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(14)61706-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C-Peptide Levels Are Associated With Mor

C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography: The LURIC study

✍ Marx, N.; Silbernagel, G.; Brandenburg, V.; Burgmaier, M.; Kleber, M. E.; Gramme 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 252 KB

ADMISSION GLUCOSE LEVEL, NOT HBA1C, PRED

ADMISSION GLUCOSE LEVEL, NOT HBA1C, PREDICT LONG–TERM MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

✍ Kim, Weon; Kim, Jin Bae; Choi, Eun Yong; Kang, Won Yu; Kim, Wan; Bae, Jong Hoa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Admission glucose, fasting glucose, HbA1

Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography

✍ Arbel, Yaron; Zlotnik, Margalit; Halkin, Amir; Havakuk, Ofer; Berliner, Shlomo; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 208 KB

AS-5: Admission Glucose Level, not HbA1C

AS-5: Admission Glucose Level, not HbA1C, Predicts Long-Term Mortality in Patients with Acute Myocardial Infarction

✍ Sang-jin Ha; Weon Kim; Tae-kyung Rhew; Su-joong Kim; Myeong-kon Kim; Woo-sik Kim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 96 KB

Long-term mortality in patients with typ

Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment

✍ Saleh, N.; Petursson, P.; Lagerqvist, B.; Skúladóttir, H.; Svensson, A.; Eliasso 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 294 KB

Long-term mortality benefit with abcixim

Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention

✍ Keaven M Anderson; Robert M Califf; Gregg W Stone; Franz-Josef Neumann; Gilles M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 213 KB